As 2026 begins, it is a good moment to reflect on the strong foundation built over the past year and the progress already underway at RegMed XB. 

The in December 2025 published independent advisory report chaired by Peter Wennink translates the findings of the Draghi report on Europe’s future earning capacity to the Dutch context.

RegMed XB proudly contributes to ATMP XB, a €3.5 million Interreg-cofunded initiative led by Biovia, aimed at reinforcing the cross-border ecosystem for ATMPs in Flanders and the South of the Netherlands.